28 results
S-3ASR
AUTL
Autolus Therapeutics plc
28 Mar 24
Automatic shelf registration
4:10pm
protection;
our ability to identify, recruit and retain qualified employees and key personnel;
our ability to contract with third-party suppliers
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
protection;
our ability to identify, recruit and retain qualified employees and key personnel;
our ability to contract with third-party suppliers … expressing T cells. The study is ongoing and continues to recruit patients.
Table of contents
Our Pipeline
Our product pipeline is built on our
424B5
AUTL
Autolus Therapeutics plc
9 Feb 24
Prospectus supplement for primary offering
5:15pm
property protection;
our ability to identify, recruit and retain qualified employees and key personnel;
our ability to contract with third-party suppliers … to obtain and maintain intellectual property protection;
our ability to identify, recruit and retain qualified employees and key personnel;
our
S-3ASR
AUTL
Autolus Therapeutics plc
7 Feb 24
Automatic shelf registration
10:00pm
expectations regarding our ability to obtain and maintain intellectual property protection;
our ability to identify, recruit and retain qualified
8-K
EX-99.1
AUTL
Autolus Therapeutics plc
11 Dec 23
Regulation FD Disclosure
8:31am
and continues to recruit patients.
4 Poster Presentations: Title: Long-Term Efficacy and Safety of Obecabtagene Autoleucel (obe-cel) in Adult Patients
10-Q
dgo0q0ixz p5x
9 Nov 23
Quarterly report
4:18pm
424B5
nz0jc2twqrom99
9 Dec 22
Prospectus supplement for primary offering
5:40pm
424B5
dmflau0oqz 4wjkbg
8 Dec 22
Prospectus supplement for primary offering
4:10pm
6-K
EX-1
yyz27frnts 10rom
1 Jul 22
Current report (foreign)
5:15pm
424B3
c9uehw02zqjhftyju
18 May 22
Prospectus supplement
4:09pm
F-3
8s1 0i1mw0q4mnd4smy
3 May 22
Shelf registration (foreign)
7:25pm
424B3
cemkc 8nauvh7c09itd
3 May 22
Prospectus supplement
4:55pm
F-3
qas6 0lpa5
14 Apr 22
Shelf registration (foreign)
9:30pm
6-K
EX-1
b774yh4zi0rli8m3
30 Jun 21
Annual Report and Accounts
6:05am
424B5
x6ynrdqlxd0p4rqda1j
11 Feb 21
Prospectus supplement for primary offering
5:16pm
424B5
q3rb1n
8 Feb 21
Prospectus supplement for primary offering
5:27pm
6-K
EX-1
u932s ofyf
26 May 20
Current report (foreign)
4:31pm